You are here: Industry Insights > COVID-19

News List

Edinburgh Uni researchers focus on drug repurposing for COVID-19 pharmatimes
April 17, 2020
Up to 150 researchers at the University of Edinburgh’s Centre for Inflammation Research are being re-deployed to work on a project that aims to repurpose existing and experimental medicines for COVID-19.
Researchers call for greater focus on mental health and brain research during pandemic pharmatimes
April 17, 2020
The Lancet Psychiatry has published a new paper highlighting an urgent need to tackle the harmful impacts of the COVID-19 pandemic on mental health and potentially the brain.
Sinovac Biotech to move ahead with COVID-19 vaccine trial in China pharmaceutical-business-review
April 17, 2020
Sinovac Biotech has secured approval in China to move ahead with a human clinical trial on an inactivated vaccine candidate against the SARS-CoV-2 virus (novel coronavirus or COVID-19).
Your nose may know more when it comes to COVID-19 worldpharmanews
April 17, 2020
A University of Cincinnati ear, nose and throat specialist says your nose may hold a clue in identifying COVID-19. The loss of smell may be a key indicator.
Boehringer Ingelheim steps up effort with Global Support Program worldpharmanews
April 17, 2020
Boehringer Ingelheim has significantly stepped up its support to the fight against COVID-19.
Depression, anxiety may be side effects as nation grapples with COVID-19 americanpharmaceuticalreview
April 17, 2020
Millions of Americans are being impacted by the psychological fallout from the COVID-19 pandemic and its economic aftermath, and large numbers may experience emotional distress ...
FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies americanpharmaceuticalreview
April 17, 2020
Statement from Stephen M. Hahn M.D., Commissioner of Food and Drugs - Food and Drug Administration.
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing americanpharmaceuticalreview
April 17, 2020
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
Roivant Doses First Patient in Gimsilumab Trial for COVID-19 Acute Respiratory Distress Syndrome Prevention americanpharmaceuticalreview
April 17, 2020
Roivant Sciences announced the first patient was dosed at Temple University Hospital in Philadelphia in an adaptive, randomized, double-blind, placebo-controlled ...
Clinical trials for COVID-19 treatments show mixed results, says study europeanpharmaceuticalreview
April 17, 2020
Despite some positive results from clinical trials for COVID-19 treatments, separate tests of the same therapies have not met primary endpoints.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page